Abstract
The structure of 4,5-diferrocenyl-1,2-dithiole-3-thione, [Fe2(C5H5)2(C13H8S3)] or C23H18Fe2S3, at 130 K has monoclinic (P21/c) symmetry. The molecule has two ferrocenyl units attached to a 1,2-dithiole-3-thione moiety. It is of interest with respect to the question if the introduction of ferrocenyl substituents into biologically active molecules offers the potential to obtain more efficacious therapeutic drugs. The crystal structure displays intermolecular contacts of the C—H...S and S—π(C—C) types.
Publisher
International Union of Crystallography (IUCr)
Subject
Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,General Medicine
Reference14 articles.
1. Agilent (2013). CrysAlis PRO and CrysAlis RED. Agilent Technologies, Yarnton, Oxfordshire, England.
2. Bian, J., Cai, Z. & Wu, H. (2012). CN Patent 102417501 A, 1.
3. Design, synthesis, and pharmacological evaluation of the aqueous prodrugs of desmethyl anethole trithione with hepatoprotective activity
4. WinGXandORTEP for Windows: an update
5. Different donor–acceptor structures of dithiafulvalene-fused semiconducting polymers with different band gaps
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献